ENLV logo

Enlivex Therapeutics (ENLV) Total Assets

Annual Total Assets

$36.83 M
-$30.81 M-45.55%

31 December 2023

ENLV Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$31.90 M
+$855.00 K+2.75%

30 June 2024

ENLV Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENLV Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-45.5%-32.0%
3 y3 years-8.7%-67.5%
5 y5 years+233.8%+66.0%

ENLV Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-61.3%at low-67.5%+2.8%
5 y5 years-61.3%+233.8%-67.5%+81.7%
alltimeall time-61.3%>+9999.0%-67.5%>+9999.0%

Enlivex Therapeutics Total Assets History

DateAnnualQuarterly
June 2024
-
$31.90 M(+2.8%)
Mar 2024
-
$31.05 M(-15.7%)
Dec 2023
$36.83 M(-45.6%)
$36.83 M(-21.5%)
Sept 2023
-
$46.94 M(-11.5%)
June 2023
-
$53.03 M(-11.7%)
Mar 2023
-
$60.02 M(-11.3%)
Dec 2022
$67.64 M(-28.9%)
$67.64 M(-6.6%)
Sept 2022
-
$72.41 M(-6.4%)
June 2022
-
$77.34 M(-12.7%)
Mar 2022
-
$88.62 M(-6.9%)
Dec 2021
$95.15 M(+135.8%)
$95.15 M(-3.1%)
Sept 2021
-
$98.17 M(+3.1%)
June 2021
-
$95.19 M(-0.8%)
Mar 2021
-
$95.96 M(+137.8%)
Dec 2020
$40.36 M(+129.8%)
$40.36 M(+20.9%)
Sept 2020
-
$33.37 M(-5.8%)
June 2020
-
$35.44 M(-5.9%)
Mar 2020
-
$37.65 M(+114.4%)
Dec 2019
$17.56 M
$17.56 M(-8.6%)
Sept 2019
-
$19.22 M(-7.7%)
DateAnnualQuarterly
June 2019
-
$20.83 M(+9.4%)
Mar 2019
-
$19.05 M(+72.6%)
Dec 2018
$11.03 M(+204.6%)
$11.03 M(+547.5%)
June 2018
-
$1.70 M(-53.0%)
Dec 2017
$3.62 M(-65.9%)
$3.62 M(-15.4%)
Sept 2017
-
$4.28 M(-22.3%)
June 2017
-
$5.51 M(-30.1%)
Mar 2017
-
$7.89 M(-25.8%)
Dec 2016
$10.63 M(-48.2%)
$10.63 M(-20.5%)
Sept 2016
-
$13.37 M(-21.1%)
June 2016
-
$16.95 M(-24.6%)
Mar 2016
-
$22.48 M(+9.6%)
Dec 2015
$20.52 M(-37.7%)
$20.52 M(-14.2%)
Sept 2015
-
$23.92 M(-11.1%)
June 2015
-
$26.90 M(-9.9%)
Mar 2015
-
$29.85 M(-9.4%)
Dec 2014
$32.95 M(>+9900.0%)
$32.95 M(-4.6%)
Sept 2014
-
$34.54 M(+664.8%)
June 2014
-
$4.52 M(+1375.8%)
Dec 2013
$306.00 K(+96.2%)
$306.00 K
Dec 2012
$156.00 K
-

FAQ

  • What is Enlivex Therapeutics annual total assets?
  • What is the all time high annual total assets for Enlivex Therapeutics?
  • What is Enlivex Therapeutics annual total assets year-on-year change?
  • What is Enlivex Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Enlivex Therapeutics?
  • What is Enlivex Therapeutics quarterly total assets year-on-year change?

What is Enlivex Therapeutics annual total assets?

The current annual total assets of ENLV is $36.83 M

What is the all time high annual total assets for Enlivex Therapeutics?

Enlivex Therapeutics all-time high annual total assets is $95.15 M

What is Enlivex Therapeutics annual total assets year-on-year change?

Over the past year, ENLV annual total assets has changed by -$30.81 M (-45.55%)

What is Enlivex Therapeutics quarterly total assets?

The current quarterly total assets of ENLV is $31.90 M

What is the all time high quarterly total assets for Enlivex Therapeutics?

Enlivex Therapeutics all-time high quarterly total assets is $98.17 M

What is Enlivex Therapeutics quarterly total assets year-on-year change?

Over the past year, ENLV quarterly total assets has changed by -$15.03 M (-32.03%)